logo

CPRX

Catalyst·NASDAQ
--
--(--)
--
--(--)
6.78 / 10
Outperform

Fundamental rating is Outperform with a 6.8/10 score. Strengths include high PB‑ROE and cash‑to‑market value, while Asset‑MV and Revenue‑MV are weaker. Inventory turnover and fixed‑asset turnover are decent, and YoY revenue growth is robust at 19.8%.

Fundamental(6.78)SentimentTechnical

Analysis Checks(7/10)

Revenue-MV
Value-0.82
Score1/3
Weight26.90%
1M Return4.95%
Total operating revenue (YoY growth rate %)
Value19.78
Score3/3
Weight6.95%
1M Return1.54%
Inventory turnover ratio
Value3.08
Score2/3
Weight-5.02%
1M Return-1.21%
Gross profit margin (%)
Value85.19
Score0/3
Weight-26.11%
1M Return-7.24%
PB-ROE
Value1.50
Score3/3
Weight55.98%
1M Return9.74%
Income tax / Total profit (%)
Value24.40
Score3/3
Weight8.13%
1M Return1.47%
Fixed assets turnover ratio
Value179.68
Score3/3
Weight4.60%
1M Return1.06%
Cost of sales ratio (%)
Value14.81
Score2/3
Weight-17.15%
1M Return-4.42%
Asset-MV
Value-0.55
Score0/3
Weight14.01%
1M Return2.69%
Cash-MV
Value-0.58
Score2/3
Weight31.70%
1M Return5.94%
Is CPRX undervalued or overvalued?
  • CPRX scores 6.78/10 on fundamentals and holds a Discounted valuation at present. Backed by its 25.49% ROE, 36.39% net margin, 14.07 P/E ratio, 3.16 P/B ratio, and 26.81% earnings growth, these metrics solidify its Outperform investment rating.